Michael Alexander
Family Medicine · Henrico, VANPI 1366779837
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 120 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,016, more than ten times the $31 reported in 2019.
Across 120 payments — averaging $20.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Braeburn Inc.$444
- Alkermes, Inc.$444
- Lilly USA, LLC$415
- Indivior Inc.$373
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$139
- Axsome Therapeutics, Inc.$130
- plus $488 from 11 others
What the payments were for
- Food & beverage$2,40699%
- Education$281%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Braeburn Inc. | 26 | $444 |
| Alkermes, Inc. | 22 | $444 |
| Lilly USA, LLC | 16 | $415 |
| Indivior Inc. | 20 | $373 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $139 |
| Axsome Therapeutics, Inc. | 5 | $130 |
| Exact Sciences | 5 | $96 |
| Orexo US, Inc. | 5 | $89 |
| AbbVie | 4 | $84 |
| Corium, LLC | 1 | $53 |
| Johnson & Johnson | 2 | $39 |
| Novo Nordisk | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $25 |
| Almatica Pharma LLC | 1 | $22 |
| Acelrx Pharmaceuticals, Inc. | 1 | $21 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Pear Therapeutics (US), Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,433 in reported general payments places this provider in the 80th percentile of 2,553 family medicine providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 382 | $66,152 |
| JardianceEmpagliflozin | 16 | $27,226 |
| OzempicSemaglutide | 26 | $25,742 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 28 | $12,382 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 13 | $6,060 |
| Buprenorphine Hcl | 93 | $4,757 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $4,191 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $1,437 |
| Morphine Sulfate | 13 | $1,131 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 42 | $1,025 |
| Sumatriptan Succinate | 15 | $737 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 34 | $552 |
| Oxycodone Hcl | 31 | $493 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 20 | $484 |
| Atorvastatin Calcium | 27 | $471 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $33 | $25,74226 claims |
| Indivior Inc.Suboxone | $373 | $12,38228 claims |
| Orexo US, Inc.Zubsolv | $89 | $6,06013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,553 family medicine providers in Virginia.
Other family medicine in Henrico
- Oluwaronke AwosikaFort Gregg Adams$397K
- Monique MatuskowitzNorfolk$110K
- Paul StairsRichmond$105K
- Edwin RobinsonRichmond$83K
- Benjamin PhilpottRocky Mount$64K
- John MolaiyArlington$64K
- Catherine VarneyZion Crossroads$47K
- Jordan TranWinchester$42K
- John ClayColonial Heights$40K
- Thomas RobesonNewport News$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.